COMMUNIQUÉS West-GlobeNewswire

pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines

07/02/2018 - 22:02

Newly Released Second Phase 3 Study Data for Durasert Three-Year Treatment for Posterior Segment Uveitis Shows Positive Efficacy and Safety Profile Maintained at 12 Months Awaiting FDA Decision to Accept NDA Submission [...]

MediciNova Announces Proposed Underwritten Public Offering of Common Stock

07/02/2018 - 22:01

LA JOLLA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

Jeff Immelt Appointed Chairman of athenahealth Board of Directors

07/02/2018 - 22:01

WATERTOWN, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that its Board of [...]

pSivida's Second Phase 3 Study for Durasert™ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months

07/02/2018 - 22:01

Highly Significant Difference Between Durasert and Sham in Prevention of Uveitis Recurrence at 12 Months Fiscal Q2 2018 Results Conference Call Scheduled for Today at 4:30 p.m.ET WATERTOWN, Mass., Feb. 07, 2018 (GLOBE [...]

Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at 14th Annual WORLDSymposium™

07/02/2018 - 22:01

Consistent and Durable Responses Across Key Measures of Safety, Functional Outcomes and Biomarkers Out to Month 12 Very Low Rate (<1%) of Infusion Associated Reactions Maintained After 550+ Infusions CRANBURY, N.J. [...]

Adverum Biotechnologies Announces Proposed Public Offering of Common Stock

07/02/2018 - 22:01

MENLO PARK, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]

Cara Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 22:01

STAMFORD, Conn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus

07/02/2018 - 22:01

SAN DIEGO and TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]

OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results

07/02/2018 - 22:00

BETHLEHEM, Pa., Feb. 07, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial [...]

The American College of Rheumatology Recommends Biosimilar Use in New White Paper

07/02/2018 - 21:57

Atlanta, Feb. 07, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) has published a new white paper , “The Science Behind Biosimilars – Entering a New Era of Biologic Therapy,” providing a [...]

Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders

07/02/2018 - 21:22

ATLANTA and SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) and Vaxart, Inc. today announced that the companies have agreed to amend the terms of their [...]

Adamas to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

07/02/2018 - 20:09

EMERYVILLE, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that Gregory T. Went, Ph.D., Founder, Chairman and Chief Executive Officer of Adamas, is scheduled to [...]

Rutgers New Jersey Medical School Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture

07/02/2018 - 19:53

PISCATAWAY, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that Rutgers New Jersey Medical School [...]

Corizon Health Names New CFO

07/02/2018 - 19:21

BRENTWOOD, Tenn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- To help meet Corizon Health’s goal of redefining the nation’s standard of excellence for correctional healthcare, CEO Steve Rector today announced Shalin Shah has [...]

News Release: Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors

07/02/2018 - 18:01

Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors PDF Version of the news release Charenton-le-Pont, France (February 7, 2018 - 6:00 p.m.) - The Board of Directors of Essilor [...]

Communiqué : Evolution de la composition du Conseil d'administration d'Essilor International (Compagnie Générale d'Optique)

07/02/2018 - 18:01

Evolution de la composition du Conseil d'administration d'Essilor International (Compagnie Générale d'Optique) Version PDF du communiqué Charenton-le-Pont, France (le 7 février 2018 - 18h00) - Le Conseil d' [...]

Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference

07/02/2018 - 17:00

CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced [...]

Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET

07/02/2018 - 16:30

RALEIGH, N.C., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced [...]

Orphan’s Court of City of Jurmala Has Appointed Older Daughter of Valerijs Maligins to be the Guardian of His Inheritance

07/02/2018 - 16:18

Olaine, 2018-02-07 16:18 CET (GLOBE NEWSWIRE) -- Orphan’s court of the City of Jurmala, after assessing the application of Irina Maligina has appointed her the guardian of inheritance of Valerijs Maligins, the verdict [...]